OLIN Corp

NYSE: OLN·Clayton, Missouri·

Price
$16.89
Base IV
$41.17

Valuation snapshot

Below base case

At $16.89, the price sits between our bear case ($3.27) and base case ($41.17).

Values per share, from an .

No growth
…
Loading earnings power
Base case
$41.17
above today's price · range $3.27–$85.14
Price vs base case
59% below
$16.89 against $41.17
Base casevalued by DCF
Price vs base
Priceclose 11‑16

The price has risen 5.3% since this valuation was struck on 2026-10-31, so some of the gap opened up after these figures were set.

Whisker on the base case runs bear $3.27 to bull $85.14. Values per share.

Price against each value

Bear case
$3.27
Price 416% above
No growth
…
—
Base case
$41.17
Price 59% below
Researched bygemini-3.8-flash-medium
Valuation Oct 31, 2026 · Price as of Nov 16, 2026How we got here

What does Olin do?

Olin Corporation manufactures and distributes industrial chemicals, including chlorine and caustic soda, epoxy resins, and sporting and military ammunition for industrial, commercial, and defense applications.

It brought in $6.7B of sales in the 12 months to Sep 2026.

Industry
Materials
Based in
Clayton, Missouri
Trades on
NYSE as OLN

Here is where each dollar a customer pays ends up. For every $1 of sales in the 12 months to Sep 2026, it spent about $1.03, so it lost 3¢ on each dollar. The biggest cost is making what it sells, 93¢ of every dollar.

$1 of sales
  • Making what it sells93¢
  • Sales, marketing and admin8¢
  • Everything else it takes to operate1¢
  • Interest and other costs2¢
  • Tax credit came back in+1¢
  • Lost on each dollar−3¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays Olin, and for what?

Olin Corporation manufactures and distributes chemical products and small caliber ammunition. It makes money by producing chlorine, caustic soda, vinyls, and epoxy resins for industrial applications, and by selling commercial, military, and sporting ammunition and targets.

Olin sells to industrial chemical users, commercial distributors, retailers, wholesalers, and the U.S. government and foreign militaries.

  • Chlor Alkali Products and Vinyls

    54%

    Manufactures chlorine, caustic soda, ethylene dichloride, vinyl chloride monomer, chlorinated organics, bleach, and hydrochloric acid.

  • Epoxy

    20%

    Produces epoxy materials and precursors including aromatics, allyl chloride, epichlorohydrin, liquid and solid epoxy resins, and formulated solutions.

  • Winchester

    26%

    Produces sporting and military ammunition, reloading components, industrial cartridges, clay targets, and contracted military project services.

Share of the latest fiscal year's sales, as the company reports it.

Where its work physically happens, beyond headquarters:

  • Freeport Chlor Alkali, Vinyls & Epoxy Complex — Freeport, United States. This is one of Olin's two largest integrated sites and sits next to Dow on land leased for 99 years from 2015; it makes chlorine, caustic soda, vinyls intermediates and epoxy, so it drives most of the Chlor Alkali Products and Vinyls segment, which was 54% of 2025 sales.
  • Plaquemine Chlor Alkali & Vinyls Complex — Plaquemine, United States. This is Olin's other largest site, also next to Dow under the 99-year land lease; its large chlor-alkali and chlorinated organics capacity is a main driver of how much the segment earns as chlorine and caustic soda prices move.
  • Lake City Army Ammunition Plant — Independence, United States. Winchester has fully run this government-owned, contractor-operated plant since October 1, 2020, making small-caliber military ammunition under a U.S. Army contract that was extended by three years; it is the core of Winchester's steady military revenue.
  • Stade Chlor Alkali & Epoxy Site — Stade, Germany. This is Olin's main European plant for chlor-alkali and epoxy; it matters for the Epoxy segment (about 20% of 2025 sales, with a loss of $103.5 million) because it is exposed to European energy costs and to competition from subsidized Asian imports.
  • McIntosh Chlor Alkali Plant — McIntosh, United States. This is a long-running Olin chlor-alkali plant making chlorine, caustic soda and bleach for the merchant market; it adds Gulf Coast capacity to the Chlor Alkali Products and Vinyls segment.
See them on the globe

Olin Corp Form 10-K for the period ending December 31, 2025

How is the business doing?

Sales grew from $5.8B in 2020 to $6.8B in 2025, about 3% a year.

It still spends more to run the business than it brings in: an operating loss of 2¢ per sales dollar, narrower than 13¢ in 2020.

After paying for its upkeep and new investment, it had $221.5M of cash to spare in the 12 months to Sep 2026.

Sales$6.8B
20162025
Operating margin0%
20162025
Free cash flow$247.9M
20162025
Each bar is one fiscal year (2016–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

Olin aims to provide essential materials and solutions that improve and protect human lives.

“We deliver essential materials and solutions that enhance and protect lives.”

Olin Corporate Responsibility and Purpose

What management says it is working on now:

Full-Year 2026 Adjusted EBITDA, Full Year 2026
$550 million to $570 million
Olin Corporation Third Quarter 2026 Financial Results
Fourth Quarter 2026 Adjusted EBITDA, Fourth Quarter 2026
$80 million to $100 million
Olin Corporation Third Quarter 2026 Financial Results
Capital Expenditures, Full Year 2026
approximately $200 million
Olin Corp Form 10-K for the period ending December 31, 2025
Clean Hydrogen 45V Pretax Annual Benefit, Annually through 2028
$15 million to $20 million
Olin Corp Form 10-K for the period ending December 31, 2025
Incremental Structural Cost Savings, Full Year 2026
$110 million to $120 million
Olin Corporation Third Quarter 2026 Earnings Call Transcript
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is holding steady. In Q3 2026 it sold 2% more than a year earlier. The year before, quarters averaged 1%.

Its operating margin is narrower than a year ago: 3¢ per sales dollar, against 5¢.

Since Oct 2026 the share price has risen 5%, from $16.04 to $16.89.

Bull $85.14Base $41.17Bear $3.27Oct 30Nov 16 · $16.89
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 30, 2026.

Coming up

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Cyclical product pricing and supply imbalances

    Profits depend heavily on chemical and ammunition prices, which fluctuate based on global capacity, oversupply, and competitor actions.

    From the company's own filingsWould hit how fast sales growOlin Corp Form 10-K for the period ending December 31, 2025

  2. Sensitivity to energy and feedstock costs

    Operations consume large volumes of electricity, natural gas, ethylene, and metals; failure to pass higher input costs to customers reduces margins.

    From the company's own filingsWould hit how much of each sale it keepsOlin Corp Form 10-K for the period ending December 31, 2025

  3. Subsidized foreign competition in Epoxy

    Olin faces severe margin pressure in epoxy resins caused by low-priced, subsidized import volumes coming out of Asia.

    From the company's own filingsWould hit how much of each sale it keepsOlin Corp Form 10-K for the period ending December 31, 2025

  4. Significant debt load and covenant restrictions

    High indebtedness restricts operational flexibility and exposes the company to debt compliance risks during economic downturns.

    From the company's own filingsWould hit how much it has to reinvestOlin Corp Form 10-K for the period ending December 31, 2025

  5. Manufacturing hazards and severe weather events

    Chemical manufacturing involves explosive materials and Gulf Coast assets vulnerable to hurricanes, unplanned outages, or transit disruptions.

    From the company's own filingsWould hit how much of each sale it keepsOlin Corp Form 10-K for the period ending December 31, 2025

  6. Customer disputes and contractual litigation

    Contract disputes, such as the VCM contract dispute with Shintech resulting in adverse verdicts and cash payments, hurt liquidity.

    From the company's own filingsWould hit how much of each sale it keepsOlin Corp Form 10-K for the period ending December 31, 2025

  7. Management guided Q4 2026 adjusted EBITDA to $80-$100 million due to normal seasonal softness and continued customer destocking in chemicals.

    From our researchWould hit how fast sales growOlin Q4 2026 Guidance Update

  8. Operating margins turned negative in late 2025 and early 2026 due to sudden operational outages and winter storms.

    From our researchWould hit how much of each sale it keepsOlin Historical Quarterly Actuals

Is it a good business?

From 2016 to 2025 it earned between -12% and 29% on the capital invested in it, a median of 4%. Its cost of capital in the latest valuation is 6.9%; returns were above it in 4 of the 10 years.

From 2016 to 2025 it earned between -67% and 52% on its shareholders' equity, a median of 8%.

Over 10 years its operating margin ranged from 13¢ to 21¢ per sales dollar, a median of 5¢. Gross margin ran from 7¢ to 26¢.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on invested capital0%
20162025

Cost of capital 6.9%

Return on equity-5%
20162025
Return on invested capital is operating profit after tax (at the median effective rate, 21%) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

The number of shares has held roughly steady over the past year.

It owes $2.8B more than it holds in cash. The latest four quarters had no positive operating profit to compare with that debt.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $16.89. Our put its value between $3.27 and $85.14, with $41.17 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $3.27

This scenario envisions prolonged weakness in global chemical demand and building activity, leaving sales near recent reduced levels of around six and a half billion dollars while severe foreign competition keeps profits near their lowest historic points.

Base case, $41.17

This scenario assumes a steady turnaround from recent sluggish chemical sales, with annual revenue gradually expanding past seven billion dollars as customer factory orders recover and ammunition shipments stay dependable.

Bull case, $85.14

This scenario anticipates a strong cyclical rebound where rising worldwide manufacturing activity and tight chemical supplies restore robust pricing and push company sales back toward eight and a half billion dollars.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects less than we do.Margin of safety: 59%

At today's $16.89, the price makes sense if sales shrink about 7.0% a year. We assume they grow 3.0%. Over the last 5 years, sales shrank 3.7% a year.

−10%−7.5%−5%−2.5%0%+2.5%+5%Price needs −7.0%Past 5 yrs −3.7%We assume 3.0%

Or, if sales grow 3.0% as we assume, the price works with a profit margin of 4.7% (we assume 7.5%).

Keep in mind: a low price can mean investors see a risk that isn't in the filings yet. Check the Full research tab for what could go wrong.

Do you think sales will shrink?

Try your own numbers

We're not very sure of this range: it scores 48 out of 100 on our checks. The weakest point is terminal-value dependency.

Test the assumptions

Our base value of $41.17 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average3.0%
  • Operating margin7.5%
  • Long-term growth rate2.5%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$41.17 143.8%

Build